WALTHAM, Mass., March 30, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the ...
Checkpoint (2022), also known as “As Though Nothing Happened,” portrays the collective trauma of Damascus through the experiences of its people across seven years, highlighting the enduring ...
WALTHAM, Mass., June 06, 2022 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (CKPT) (Checkpoint) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced the ...